AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
RADIESSE has 20.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: RADIESSE (radiesse.com)
RADIESSE is a low-BS, high-compliance site that prioritizes pharmaceutical rigor over marketing fluff. While the hero-section copy is undeniably ‘lifestyle-heavy,’ the underlying data architecture of clinical trial results and peer-reviewed citations creates a significant buffer against bullshit. The score is only elevated by the lack of structured data and a handful of stale legacy citations.
Implement Organization and Physician/Person schema to bridge the authority gap and link named consultants to their professional footprints. Replace poetic H2 headings like ‘love letter from your future self’ with benefit-oriented, specific nouns to reduce heading fluff saturation. Update stale citations from 2008/2010 with more recent post-market surveillance data or longitudinal studies from 2024-2025. Add direct outbound links to PubMed or ClinicalTrials.gov for the 11 cited references to improve the proof path transparency.
The site exhibits a dual personality: H1 and H2 headings are highly fluffy and poetic, such as ‘With love from your future self’ and ‘every day is a love letter.’ However, the body text is exceptionally dense with substance, citing specific volumes of product (4.3 cc of RADIESSE (+)), patient ages (Jackie, 52; Debra, 62), and 11 distinct clinical references including peer-reviewed journals like Dermatol Surg and Aesthet Surg J. The specificity absence is 0, as the site provides granular trial data including ’23x more collagen’ and ‘96% more elastin’ based on human tissue studies.
Black hole nodes and terminal leaf pages distort your hierarchy and weaken retrieval. Run a full Internal Linking Architecture analysis to expose the structural gaps hidden inside your graph.
There is zero semantic drift across the four pages; the homepage promise of ‘biostimulation’ and ‘regenerative power’ is consistently supported by technical sub-pages explaining the CaHA microsphere scaffold and non-inflammatory pathways. The transition from the emotional hook on the homepage to the ‘GLP-1 journey’ specific positioning on the Discover page shows a highly coherent strategy targeting facial volume loss. Even the footer safety information remains consistent and verbatim across all URL slots.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
Trust theatre is minimal because the site relies on peer-reviewed citations rather than unverified social proof. While the review_count of 3 is low, the citations_count of 11 on the homepage alone provides a high-integrity proof path. The trust_theatre_flag is false as the ‘Actual patient’ claims are accompanied by detailed treatment plans and post-injection timelines, though the site does use standard ‘Individual results may vary’ disclaimers.
Proof density is extremely high for the aesthetics category, with a ratio of approximately one clinical citation for every three paragraphs of marketing text. The site provides specific ‘Instructions for Use’ (IFU) references from 2023 and data on file from 2025. However, several foundational citations (Bass et al., 2010; Tzikas, 2008) are older than 36 months, making them ‘stale’ evidence in the context of the May 2026 system date.
To review a full competitive diagnostic applied to an enterprise level technical SEO agency, including a direct comparison against Dejan, examine the complete executive audit. View the iPullRank Executive SEO Strategy Dashboard for a practical example of how perception gaps, value prop drift, and audience misalignment are surfaced in real audits.
The site uses standard industry clichés like ‘FDA-approved’ and ‘clinically proven,’ but these are justified by specific trial numbers (n=117, n=120) and study designs (randomized, split-face). The value proposition is differentiated by the ‘Biostimulator’ category vs generic ‘Dermal Filler’ positioning. Template language is only present in the regulatory safety sections, which are legally mandated and thus exempt from typical commodity penalties.
A notable authority gap exists in the technical implementation; the schema_json is null across all pages, missing critical Organization or MedicalBusiness structured data. While ‘Dr. David Funt’ is named as a consultant, there is no Person schema or sameAs links to verify his medical credentials within the site’s metadata. This lack of a technical footprint for named authorities creates a disconnect between the brand’s established stature and its digital identity data.
Marketing claims such as ‘reversing visible signs of aging’ are bold but are immediately tethered to 18-month and 3-year clinical studies. The only disconnect is the ‘future self’ poetic framing, which is a marketing overlay on top of very rigid pharmaceutical data. Unlike most cosmetic sites, this site defines its terms (e.g., ‘Angiogenesis’, ‘Proteoglycans’) with technical citations rather than vague adjectives.
Medical Devices, Pharma & Biotech BS: RADIESSE (radiesse.com)
The content perfectly aligns with the Medical Device and Pharmaceutical industries, characterized by heavy regulatory disclosures, clinical trial citations, and FDA-approved indications for use. The presence of ‘Important Safety Information’ (ISI) blocks and specific product contraindications confirms a high-compliance medical environment.
If your entity graph is unstable, every other part of the framework inherits that instability. Study the Structured Data Framework Guide and see why schema is not markup — it is the machine readable definition of your domain.
“The score of 20 is driven primarily by the high 'Information Density' sub-score for poetic headings (9 pts) and the 'Identity & Authority' gap caused by the total absence of schema (5 pts). The site achieved a perfect 0 in 'Semantic Coherence,' indicating a rock-solid alignment between marketing claims and technical delivery. Industry-specific jargon was properly identified as technical substance, preventing an inflated commodity penalty.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 24, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at RADIESSE to view the most current version of their content and see directly what the company offers.